Maynard Um
-
-
-
-
-
-
-
BMO Capital Starts Ionis Pharmaceuticals (IONS) at Market Perform
-
-
-
-
-
-
-
Raymond James sees potential for beats across biopharma coverage
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Lowered to $95 at Canaccord
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Lowered to $94 at TD Cowen
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 29c ; Offers Guidance
-
-
-
-
-
-
-
RBC Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)
-
445,670 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

